Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
CRYPTO
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
TECHNOLOGY
Search
Michael Latwis
Articles From This Author
MARKETS
Charles River Getting Back on Course
By Michael Latwis
Dec 15, 2006 3:37 PM EST
MARKETS
Beauty Stock Shakeout
By Michael Latwis
Dec 13, 2006 7:35 AM EST
MARKETS
Pfizer's Worst-Case Scenario
By Michael Latwis
Dec 5, 2006 7:50 AM EST
MARKETS
Expectations Deflated for Alkermes
By Michael Latwis
Dec 1, 2006 3:17 PM EST
MARKETS
Dendreon's Risks Will Yield Rewards
By Michael Latwis
Nov 15, 2006 7:42 AM EST
MARKETS
Lilly Deserves a Gilding
By Michael Latwis
Nov 8, 2006 7:41 AM EST
MARKETS
For ADHD, Focus on Shire, Not New River
By Michael Latwis
Nov 1, 2006 7:40 AM EST
INVESTING
Straight Dope on Drug Stocks
By Michael Latwis
Oct 18, 2006 7:44 AM EDT
INVESTING
Pick Pleasurable Side of Pure Pain Play
By Michael Latwis
Oct 5, 2006 7:44 AM EDT
INVESTING
Stent Makers Hit Blockage
By Michael Latwis
Sep 29, 2006 4:46 PM EDT
STOCKS
All Eyes on ICDs at Medtronic
By Michael Latwis
Feb 21, 2006 12:37 PM EST
STOCKS
Key Events Nearing for Biogen Idec, but Upside Looks Limited
By Michael Latwis
Feb 15, 2006 10:00 AM EST
STOCKS
Barr Should Get Earnings Boost From Key Drugs
By Michael Latwis
Feb 6, 2006 5:58 PM EST
STOCKS
More Upside Expected From Genentech
By Michael Latwis
Jan 10, 2006 9:32 AM EST
